Form 4: Inari Medical's Chief Medical Officer, Thomas Tu, Sells Shares Under 10b5-1 Trading Plan

Thomas Tu, Chief Medical Officer of Inari Medical, Inc., sold a portion of his holdings in common stock on July 15, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On July 15, 2024, Thomas Tu, the Chief Medical Officer of Inari Medical, Inc., executed multiple sales of Inari Medical's common stock.
• The sales were conducted under a pre-existing Rule 10b5-1 trading plan adopted on November 11, 2023.
• A total of 9,920 shares were sold at a weighted average price of $55.09.
• An additional 3,300 shares were sold at a weighted average price of $55.08.
• Another 3,300 shares were sold at a weighted average price of $55.10.
• Following these transactions, Thomas Tu directly owns 313,257 shares of Inari Medical common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock sales by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider. It's common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of insider trading.

Stakeholder Impact

• The stock sale by a company insider could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates